Ryman Healthcare executives gain shares from performance rights vesting

On August 29, 2025, Ryman Healthcare will issue 16,297 ordinary shares to senior executives as performance share rights granted under the Long Term Incentive Plan (LTIP) vest. These shares will be issued for no cash consideration and will rank equally with existing ordinary shares on issue, a vesting authorized by a board resolution dated July 29, 2025.

This issuance will increase Ryman Healthcare's total number of ordinary shares (excluding treasury stock) to 1,015,729,081. The 16,297 shares represent 0.001604% of the total class of financial products in existence before the issuance. Ryman Healthcare now has 1,670,340 unlisted performance share rights with varying vesting periods still on issue under the LTIP.

The share rights were part of a transition from a previous leadership share scheme with time-based vesting conditions. Further details on the LTIP and these performance share rights can be found in Ryman’s annual report and their NZX announcement on September 23, 2024.